NCT06438601

Brief Summary

This study aims to compare the short-term clinical performance of the two study contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 24, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 24, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2024

Completed
12 months until next milestone

Results Posted

Study results publicly available

August 11, 2025

Completed
Last Updated

August 11, 2025

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

May 24, 2024

Results QC Date

May 30, 2025

Last Update Submit

July 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subjective Distance Vision

    Subjective Distance Vision will be measured on a scale from 0-100 (Where 0= Extremely poor. Intolerable. Lenses cannot be worn. 100= Excellent. Unaware of any visual loss).

    At the end of 15 minutes of daily wear

Study Arms (2)

Lens A (omafilcon A)

EXPERIMENTAL

All participants will wear lens A for 15 minutes (Period 1).

Device: Lens A (omafilcon A)

Lens B (comfilcon A)

EXPERIMENTAL

All participants will wear lens B for 15 minutes (Period 2).

Device: Lens B (comfilcon A)

Interventions

15 minutes of daily wear.

Lens A (omafilcon A)

15 minutes of daily wear.

Lens B (comfilcon A)

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • They are aged 35 years or over and have capacity to volunteer.
  • They understand their rights as a subject and are willing to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They agree not to participate in other clinical research for the duration of this study.
  • They are currently wearing soft contact lenses or have done so within the past 12 months.
  • They have a spherical prescription between +10.00 and -10.00DS inclusive, (based on the ocular refraction).
  • They have astigmatism of between -0.75 and -5.75DC (based on the ocular refraction) in each eye.
  • They have a reading addition component to their spectacle refraction of between +0.75 and +2.50DS.
  • They can be satisfactorily fitted with the study lenses.
  • They own a wearable pair of spectacles.

You may not qualify if:

  • They have an ocular disorder which would normally contraindicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medications such as eye drops or ointment.
  • They have had cataract surgery.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
  • They have eye or health conditions including immunosuppressive or infectious diseases which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction.
  • They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Manchester

Manchester, United Kingdom

Location

MeSH Terms

Conditions

AstigmatismPresbyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Jose A. Vega, OD, MSc, PhD
Organization
CooperVision, Inc.

Study Officials

  • Carole Maldonado-Codina, PhD,MCOptom

    Eurolens Research

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2024

First Posted

June 3, 2024

Study Start

April 24, 2024

Primary Completion

August 15, 2024

Study Completion

August 15, 2024

Last Updated

August 11, 2025

Results First Posted

August 11, 2025

Record last verified: 2024-05

Locations